← Open Payments lookup

SUSAN WOLLENBURG: Open Payments

NPI 1164740478 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$284 in 14 payments from 11 companies in 2025. Trend: 2023 $387 · 2024 $155 · 2025 $284

Food & beverage: $284
CompanyPaymentsAmount
ABBVIE INC.2$58
Sumitomo Pharma America, Inc.2$43
Otsuka America Pharmaceutical, Inc.2$42
Medtronic, Inc.1$25
BioMarin Pharmaceutical Inc.1$22
SANOFI-AVENTIS U.S. LLC1$19
Lilly USA, LLC1$17
Lundbeck LLC1$16
Novo Nordisk Inc1$15
Amgen Inc.1$14

Products named: REXULTI, GEMTESA, QULIPTA, UBRELVY, SYMPLICITY G3, VOXZOGO 1.2mg, TZIELD, MOUNJARO.

Industry payments across NE — which companies pay providers there.